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Background: Tears of the rotator cuff are one of the most common tendon disorders. Treatment often includes surgical repair, but
the rate of failure to gain or maintain healing has been reported to be as high as 94%. This has been substantially attributed to the
inadequate capacity of tendon to heal once damaged, particularly to bone at the enthesis. A number of strategies have been
developed to improve tendon-bone healing, tendon-tendon healing, and tendon regeneration. Scaffolds have received consid-
erable attention for replacement, reconstruction, or reinforcement of tendon defects but may not possess situation-specific or
durable mechanical and biological characteristics.
Purpose: Toprovide anoverviewof thebiologyof tendon-bonehealing and the current scaffolds used to augment rotator cuff repairs.
Study Design: Systematic review; Level of evidence, 4.
Methods: A preliminary literature search of MEDLINE and Embase databases was performed using the terms rotator cuff scaffolds,
rotator cuff augmentation, allografts for rotator cuff repair, xenografts for rotator cuff repair, and synthetic grafts for rotator cuff repair.
Results: The search identified 438 unique articles. Of these, 214 articles were irrelevant to the topic and were therefore excluded.
This left a total of 224 studies that were suitable for analysis.
Conclusion: A number of novel biomaterials have been developed into biologically and mechanically favorable scaffolds. Few
clinical trials have examined their effect on tendon-bone healing in well-designed, long-term follow-up studies with appropriate
control groups. While there is still considerable work to be done before scaffolds are introduced into routine clinical practice, there
does appear to be a clear indication for their use as an interpositional graft for large and massive retracted rotator cuff tears and
when repairing a poor-quality degenerative tendon.
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Rotator cuff tears affect 30% to 50% of patients older than
50 years and are a common cause of function-limiting pain
and weakness of the shoulder.29,61 Many patients choose to
have surgery due to disabling or progressive symptoms,
and this has been reflected in a 500% increase in the rate
of repair since 2001.25 In the United States, an estimated
75,000 rotator cuff surgeries are performed annually, and
this number is likely to increase given an aging population
with greater functional demands.54
Understanding the pathoanatomy of rotator cuff tears
has improved over thepast decade, and treatment strategies
have evolved considerably. Poor biological healing is still
problematic, with failure of tendon-bone fixation occurring
in up to 26% of small tomedium tears and up to 94% in large
and massive tears.8,20,27,31,48 The cause of the high retear
rate is probably multifactorial in nature and may be attrib-
uted to the older age of the patient, quality of the tissue,
chronicity and size of the tear,muscle atrophy, fatty infiltra-
tion, bone mineral density, and repair technique (single- vs
double-row repair).11,12,15,52 In selected patients, mechani-
cal and biological enhancement of the tendon-bone interface
is therefore crucial to a successful outcome after surgery.2
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A number of synthetic and natural biomaterials have
been developed into scaffolds. Those derived from extracel-
lular matrices are thought to provide an ideal chemical and
structural milieu upon which tissue integration can occur.
Alternatively, synthetic scaffolds are predominantly used
for their mechanical stability, although more recently their
function has been enhanced by the addition of several
growth factors.59,61 Several constructs have emerged over
the years, but due to concerns over adverse host reactions,
poor integration, and high retear rates, none have been
implemented into routine clinical practice. The ideal mate-
rial should be able to meet the physiological demands of the
native tendon while providing an environment that pro-
motes host cell–mediated healing and regeneration of a
functional enthesis.
This article reviews the biology of tendon-bone healing
and the current scaffolds that are used for rotator cuff
repair. In doing so, we will then discuss limitations in the
literature and future areas of study.
METHODS
In December 2014, a preliminary literature search of MED-
LINE and Embase databases was undertaken using the
terms rotator cuff augmentation, rotator cuff scaffolds, allo-
grafts for rotator cuff repair, xenografts for rotator cuff
repair, and synthetic grafts for rotator cuff repair. A single
reviewer screened the results, and all articles examining
rotator cuff repair using scaffolds were included.
A total of 443 articles were found (including duplicates)
after searching each of the 5 search terms. After removing
5 duplicates, 438 unique articles remained. Of these, 214
articles were irrelevant to the topic and were therefore
excluded. This left a total of 224 studies that were suitable
for analysis.
Rotator Cuff Healing
The rotator cuff often ruptures at its bony insertion.25 Sur-
gical reattachment has continued to pose a significant chal-
lenge due to the contrasting mechanical properties of
tendon and bone. The difference in stiffness between the
2 materials generates high intrinsic tissue and intercellu-
lar stresses at the adjoining interface (enthesis). The intact
healthy enthesis promotes progressive transfer of force
(loading) between tendon and bone through its layered
architecture, which defines its mechanical behavior. The
enthesis has 2 forms: direct and indirect.57 Indirect
entheses attach to the metaphysis and diaphysis of bone
by merging with periosteum via the superficial layers of
tendon, supported by deeper penetrating Sharpey fibers
anchoring it to the underlying bone. In contrast, a direct
enthesis, such as the rotator cuff, inserts onto bone by a
layered structure comprising 4 distinct tissue types. These
are, in order, tendon, demineralized fibrocartilage, minera-
lized fibrocartilage, and bone.14 The principal role of the
fibrocartilaginous region is to dissipate stress concentra-
tions at the bony insertion. The demineralized component
resists compression within the distal tendon, and the
mineralized component resists shearing across the bone
surface.7
Healing of the rotator cuff takes place in 3 stages. Ini-
tially, there is an inflammatory phase with subsequent
removal of tissue debris by macrophages. This is followed
by fibroblast infiltration and the deposition of type III
collagen to form callus. Once this collagen-rich extracellu-
lar matrix has been laid down, it is remodeled causing
scar contraction. The resultant tissue has a higher ratio
of type III collagen to type I collagen, a property that
renders it weaker and more prone to rerupture.6,19,21,29,45
One factor that may contribute to the formation of this
scar tissue is the mechanical strain during the initial
phases of healing. At birth, the rotator cuff tendon tissue
is attached to the perichondrium of the cartilaginous
humeral head by an immature attachment that bears no
histological resemblance to the adult insertion site. This
changes first at 7 days postnatally, where a fibrocartilagi-
nous bridge is seen, and then at 56 days postnatal, where
the typical 4 zones of the enthesis are visible. Since the
mechanical environment changes substantially after
birth, it is plausible that this is the primary agonist for
change.19 Furthermore, studies have indicated that com-
pressive forces lead to the production of proteins associated
with fibrocartilage (eg, aggrecan) and tensile forces lead
to the production of proteins associated with tendon (eg,
type I collagen).17,55 Other factors contributing to a poor
healing response include an inadequate population of
undifferentiated stem cells at the healing tendon-bone
interface, the presence of macrophages at the site of
tissue injury, and insufficient bony ingrowth into the ten-
don.6,32 Several techniques have been used to augment
healing, but few have enhanced bone incorporation into the
enthesis.30,50,51 This step in improving healing after rotator
cuff repair may be elusive.
Augmentation With Scaffolds
Scaffolds are used in orthopaedic surgery to induce native
tissue growth. In their simplest form, they may be com-
posed of an acellular extracellular matrix acting as a tissue
bridge between tendon and bone to facilitate aligned cellu-
lar growth and collagen deposition.1 This basic model has
been developed over recent years to incorporate biological
components such as stem cells and growth factors to pro-
mote regeneration of a naturally graded enthesis.46,59 Cur-
rently, there are 3 forms of tendon scaffolds: xenografts,
allografts, and synthetic matrices (Tables 1 and 2).
Xenografts. Extracellular matrices derived from either
xenogenic or allogenic material are excellent 3-dimensional
(3D) scaffolds for tissue engineering and can be utilized
for the surgical regeneration of musculoskeletal, dermal,
cardiovascular, and gastrointestinal tissues.18 To avoid
adverse immune reactions, a rigorous decellularization
process is an important step in the development of these
biological scaffolds. This can be accomplished by using
gamma irradiation or physical, chemical, or enzymatic tech-
niques. Physical methods entail freezing or mechanical
agitation to lyse native cells, whereas chemical-based stra-
tegies use hypotonic solutions or detergents to lyse the cells
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in the harvested tissue, which is then washed to remove
them. Trypsin, an enzyme that hydrolyzes proteins, is found
in the digestive systemof vertebrates.Whenused as a single
agent, it is capable of degrading cellular material within a
matrix, but its effect canbe enhancedwhenused in combina-
tion with gamma irradiation.10,18
Porcine small intestinal submucosa contains type I col-
lagen and growth factors such as fibroblast growth
factor–2 (FGF-2), transforming growth factor–b (TGF-b),
and vascular endothelial growth factor (VEGF).4,37 It has
been used as a biological scaffold that can support cellular
attachment and result in angiogenesis and collagen forma-
tion, thus forming a structure similar to that of the native
enthesis.40 Zalavras et al60 used porcine small intestinal
mucosa to reconstruct a large supraspinatus tendon defect
in a rat model. No adverse reactions were identified. At 16
weeks, the graft group demonstrated fibroblastic ingrowth,
neovascularization, and a collagenous extracellular neoma-
trix. In contrast, the nonaugmented group exhibited a dis-
organized fibroblastic response. The small intestinal
submucosa group also demonstrated a significantly higher
ultimate force to failure than the nonaugmented group.
Nicholson et al41 evaluated 2 commercially available xeno-
grafts (porcine acellular dermal patch and porcine small
intestinal mucosa) in a sheep model of infraspinatus
detachment. At 24 weeks, porcine dermal patches were
integrated into adjacent tendon tissues, whereas a more
diverse tissue response was seen with small intestinal sub-
mucosa. This was characterized by the formation of ectopic
bone and fibrocartilage. Failure loads were identical
between groups at 24 weeks.
Clinical studies evaluating the efficacy of porcine xeno-
grafts to augment rotator cuff tears have had varied
results. In one of the few randomized controlled trials
investigating rotator cuff healing with a xenograft, Ian-
notti et al27 treated 15 shoulders with porcine small intest-
inal mucosa (Restore Orthobiologic Implant; DePuy) and
compared them with 15 traditional open repairs. No sig-
nificant improvement in healing or functional outcome
was found.
TABLE 1
Clinical Studies Investigating Scaffolds Used for Augmentation of Rotator Cuff Repairsa
Type of
Scaffold Study
Level of
Evidence Tear Size
Exclusion
of Tears
With Fatty
Infiltration Sample Size
Follow-up
Period
(Range)
Failure Rate on
USS/MRI Functional Outcome Adverse Events
Porcine small
intestinal
mucosa
Iannotti et al27 2 (prospective
RCT)
Large and massive (4
cm)
No CG: 15
AG: 15
14 mo
(12-26.5 mo)
CG: 6/15
AG: 11/15
No difference between
groups using PENN
AG: 3/15
postoperative
inflammatory
reaction
Phipatanakul
and Petersen42
4 (case series) Massive tears
(5 cm)
No 11 26 mo
(14-38 mo)
5/9 Significant improvement
in UCLA and ASES
scores
3/11 postoperative
inflammatory
reaction
Walton et al56 3 (case-control) — No CG: 16
AG: 15
24 mo CG: 7/12
AG: 6/10
AG had significantly less
lift-off strength, and
significantly less
strength in internal
rotation and adduction
than the CG
AG: 4/10
postoperative
inflammatory
reaction
Porcine dermal
collagen patch
Badhe et al3 4 (case series) Tears 5 cm No 10 4.5 y (3-5 y) 2/10 Significant improvement
in Constant score
None
Porcine dermal
extracellular
tissue matrix
Gupta et al24 4 (case series) Full-thickness
supraspinatus tear with
5 cm retraction/full-
thickness 2-tendon tear
Yes 26 32 mo
(24-40 mo)
1/26 Significant improvement
in ASES and SF-12
scores
None
Acellular dermal
matrix
Bond et al9 4 (case series) Tears that were 5 cm or
involved 2 tendons, or
both
No 16 26.7 mo
(12-38 mo)
3/16 Significant improvement
in UCLA and Constant
scores
None
Barber et al5 2 (prospective
RCT)
Large (3 cm) 2-tendon
tears
No CG: 20
AG: 22
24 mo
(12-38 mo)
CG: 9/15
AG: 3/20
AG exhibited
significantly better
ASES and Constant
scores
None
Gupta et al23 4 (case series) Full-thickness rotator cuff
tear with >5 cm
retraction
Yes 24 36 mo
(29-42 mo)
1/24 Significant improvement
in ASES and SF-12
scores
None
Absorbable
collagen and
nonabsorbable
polypropylene
patch
Ciampi et al13 3 (cohort
study)
Full-thickness, 2-tendon
tear with <2 cm
postoperative residual
retraction
Advanced
fatty
infiltration
excluded
Collagen: 49
Polypropylene: 52
CG: 51
36 mo Collagen: 25/49
Polypropylene: 9/52
CG: 21/51
UCLA scores at 36
months were
significantly higher for
the polypropylene
group. Elevation and
strength of the
polypropylene group
were significantly
higher than those of
the other groups
None
Absorbable poly-
L-lactic acid
Proctor43 4 (case series) Large to massive (2 or 3
tendons) tears with 3
cm retraction
No 18 42 mo
(35-47 mo)
3/18 Significant improvement
in ASES score
None
Lenart et al33 4 (case series) Massive tear (complete
detachment of at least 2
tendons)
No 16 1.5 y
(1.2-1.7 y)
8/13 Significant improvement
in ASES and PENN
scores
None
aAG, augmentation group; ASES, American Shoulder and Elbow Surgeons; CG, control group; MRI, magnetic resonance imaging; PENN,
PENN Shoulder Score; RCT, randomized controlled trial; USS, ultrasound scan; SF-12, Short Form–12; UCLA, University of California, Los
Angeles.
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Phipatanakul and Petersen42 used porcine small intest-
inal mucosa to augment the repair of massive rotator cuff
tears. Despite an improvement in functional outcome scores,
only 44% of repairs were partially or completely intact post-
operatively. Furthermore, 3 complications occurred, includ-
ing 1 infection and 2 skin reactions. Poor results were also
reported by Walton et al,56 who found that patients whose
rotator cuffs were repaired using the Restore Orthobiologic
Implant, a collagen-based material derived from the small
intestinal mucosa of pigs, had decreased muscle strength,
greater impingement in external rotation, slower rate of
pain resolution, and reduced participation in sport. Two
years postoperatively, magnetic resonance imaging demon-
strated comparable retear rates between the study group
and nonaugmented controls. Because of the high number
of severe inflammatory reactions that required further sur-
gery, use of this implant was discouraged. Malcarney
et al34 also described this reaction in a series of 4 cases, and
Zheng et al62 reported that it may be due to residual porcine
cellular elements in the graft.
Porcine dermal collagen has been shown to support fibro-
blast infiltration and revascularization and has been used
in the reconstruction of human soft connective tissue
defects where loss of the dermis has occurred. Badhe
et al3 reported a series of 10 patients in whom a porcine der-
mal collagen patch was incorporated in open repairs of
extensive rotator cuff tears. These tears were at least
5 cm in size and involved both the supraspinatus and infra-
spinatus tendons. Pain, range of movement, and functional
outcome improved significantly. No adverse effects were
reported, but the evidence was limited by the lack of a suit-
able control group. Gupta et al24 studied 26 patients who
underwent interpositional reconstruction of 2-tendon or
massive, irreparable rotator cuff tears using Conexa xeno-
graft (Tornier Inc). At a minimum 2-year follow-up, there
was improvement in range of movement and functional out-
come, as assessed by the American Shoulder and Elbow
Surgeons (ASES) score. One failure was noted after a
fall that caused a complete tear at the graft-bone inter-
face due to suture anchor pullout. No cases of infection,
inflammatory changes, or tissue rejection were found.
Comprehensive processing of the graft in addition to its
noncrosslinked structure was thought to be responsible for
the lack of an adverse reaction.
The current body of evidence suggests that xenografts
do not appear to enhance rotator cuff repair in humans,
with retear rates similar to nonaugmented controls.27,56
Major concerns have also been raised over their immuno-
genic potential and associated severe inflammatory reac-
tions.34,62 This is most likely due to traces of DNA and
TGF-b remaining in the graft material despite thorough
decellularization. Another less commonly found cell-
associated marker responsible for hyperacute rejection of
porcine xenografts is galactose-a-1,3-galactose (a-Gal). The
a-Gal epitope is synthesized on glycolipids and glycopro-
teins present in nonprimate mammals by the glycosylation
enzyme a-1,3-galactosyltransferase. This epitope, is not
present in humans, who instead have the anti-Gal anti-
body, which constitutes approximately 1% of circulating
immunoglobulins and specifically targets a-Gal.35,36,62
Allografts. Allogenic matrices are produced by the decel-
lularization of cadaveric material from humans and are
capable of bridging soft tissue defects while reducing the
risk of graft rejection. Ide et al28 used acellular dermal
matrix (GraftJacket; Wright Medical Technology) in a rat
model to reconstruct large rotator cuff tears and induce ten-
don regeneration. When compared with untreated controls,
the graft group exhibited a greater mean ultimate force to
failure and superior histological outcomes with fibroblastic
ingrowth at the tendon-bone interface, neovascularization,
and production of a collagenous extracellular matrix. Fibro-
blasts were also oriented along stress lines, and the graft
could not be identified in any of the specimens. Adams
et al1 compared human acellular dermal matrix graft
(GraftJacket) with an autologous excised tendon used to
repair a full-thickness infraspinatus tear in a canine model.
Within 6 weeks of application, the dermal matrix displayed
evidence of native cell infiltration and neotendon develop-
ment. At 12 weeks, the strengths of the 2 repairs were com-
parable, and at 6 months, a remodeled tendonlike structure
characterized by Sharpey fibers was visible in the graft
group.
A number of human studies have also examined the
effect of acellular dermal matrix on rotator cuff repair.
Bond et al9 reviewed the outcome of 16 patients with mas-
sive, contracted, immobile rotator cuff tears that were
treated with arthroscopic placement of a GraftJacket allo-
graft. This yielded a failure rate of 19%, which is consider-
ably lower than the 30% to 94% quoted in the literature.29
No complications were noted, and follow-up analysis of the
graft at 12 months illustrated its viability. Furthermore, in
1 of the patients who had a documented failure, a biopsy
revealed partial neotendon formation at the site of graft
insertion. Histological analysis of the remaining specimens
was not undertaken, and therefore, the extent of any ten-
don remodeling remains unknown. Barber et al5 further
assessed the effectiveness of the GraftJacket in a rando-
mized, prospective, multicenter clinical study of 42 patients
undergoing arthroscopic repair of large (>3 cm) rotator cuff
tears. At 24-month follow-up, using the ASES and Constant
scores, superior functional outcomes were noted in the aug-
mented group compared with the nonaugmented controls.
Significantly more intact repairs were also found in the
GraftJacket group using enhanced magnetic resonance
imaging, and no adverse reactions related to the acellular
human dermal matrix were observed. Similar results were
found by Gupta et al,23 who examined 24 patients who
underwent interpositional repair of massive irreparable
rotator cuff tears using the GraftJacket. At a mean 3-year
follow-up, range of movement and ASES scores signifi-
cantly improved after surgery. Ultrasonography demon-
strated fully intact repairs in 76% of the cohort, with all
remaining patients having partially intact repairs. No com-
plete tears were found.
Although the results of acellular dermal matrices are
promising, there have been no large human studies con-
ducted evaluating their effectiveness. Bony ingrowth into
a healing tendon is crucial for regeneration of a functional
enthesis, but little sign of this is seen with current allo-
grafts.6 Despite no serious complications being reported,
4 Thangarajah et al The Orthopaedic Journal of Sports Medicine
there are some potential problems with allogenic matrices.
Like xenografts, there have been concerns over the pres-
ence of residual DNA.22 This may cause an inflammatory
response and increase tendon degeneration.62 It has also
been shown that the elastic moduli of allografts are less
than that of autogenic tendons, suggesting that they have
a limited mechanical role.16
Synthetic Grafts. Because of ongoing concerns regarding
the immunogenicity of both xenografts and allografts, there
has been considerable interest in synthetic constructs.
Degradable polyesters such as poly(lactic-co-glycolic) acid
(PLGA), poly-L-lactic acid (PLLA), and polydioxanone
(PDO) have emerged as potential biomaterials to create this
novel group of implants.25 On their initial conception, rap-
idly absorbable sheets of polyglycolyic acid (PGA) were used
to regenerate the enthesis; however, they displayed poor
mechanical properties and created a tendon insertion com-
prised primarily of type III collagen.58
Moffat et al39 conducted an in vitro evaluation of well-
aligned and unaligned electrospun degradable PLGA-based
TABLE 2
Animal Studies Investigating Scaffolds Used for Augmentation of Rotator Cuff Repairs
Type of Scaffold Study Animal Model
Host
Response Histological Data Biomechanical Data
Porcine small
intestinal
submucosa and
acellular
porcine dermal
patch
Nicholson
et al41
Ovine,
infraspinatus
detachment
No adverse
reaction
At 24 weeks, porcine dermal
patches were integrated into
adjacent tendon tissues. A more
diverse tissue response was seen
with small intestinal submucosa.
This was characterized by the
formation of ectopic bone and
fibrocartilage
At 24 weeks, failure loads were
identical between groups
Porcine small
intestinal
submucosa
Zalavras
et al60
Rat, supraspinatus
detachment and
creation of a
large 4-mm
defect
No adverse
reaction
At 16 weeks, the graft group
exhibited fibroblastic ingrowth,
neovascularization, and a
collagenous extracellular
neomatrix. In contrast, the
nonaugmented group
demonstrated a disorganized
fibroblastic response lacking any
orientation
The small intestinal submucosa
group demonstrated a
significantly higher ultimate
force to failure than the
nonaugmentation group
Acellular dermal
matrix
Ide et al28 Rat, supraspinatus
and
infraspinatus
detachment
No adverse
reaction
Histologic incorporation of the graft
into a structure resembling
normal tendon at 12 weeks after
surgery
Nonaugmentation group exhibited
lower mean ultimate force to
failure
Adams
et al1
Canine,
infraspinatus
excision
No adverse
reaction
Within 6 weeks, histologic evidence
of native cell infiltration and
neotendon development was
observed
Within 12 weeks, the strength of
the dermal matrix graft repair
was equivalent to that of
autograft control tendon repairs
PGA sheet Yokoya
et al59
Rabbit, full-
thickness defect
of rotator cuff
No adverse
reaction
In the MSC group, fibrocartilage
layers and Sharpey fibers were
found regularly in the insertion
site at 8 weeks compared with
PGA alone. A large volume of
type I collagen was found in
comparison with type III collagen
at 16 weeks in the MSC group,
whereas type III collagen was
more prevalent than type I in the
PGA group
At 16 weeks, regenerated tendons
in the MSC group had better
tensile strength than in the PGA
bFGF-loaded
PLGA
electrospun
fibrous
membrane
Zhao
et al61
Rat, chronic rotator
cuff tear model
No adverse
reaction
PLGA membrane was associated
with improvements in
fibrocartilage and collagen
organization at the healing
enthesis compared with rotator
cuff repair without
augmentation. The bFGF-loaded
PLGA membranes significantly
improved collagen organization
Electrospun fibrous membrane
groups had a greater ultimate
load to failure and stiffness than
the control group at 4 and 8
weeks. The bFGF-loaded PLGA
membranes had the highest
ultimate load to failure, stiffness,
and stress of the healing enthesis
abFGF, basic fibroblast growth factor; MSC, mesenchymal stem cell; PGA, polyglycolic acid; PLGA, poly(lactic-co-glycolic acid).
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nanofiber scaffolds with pre-engineered mechanical prop-
erties matching those of the native tissue. Scaffolds con-
sisting of well-aligned nanofibers were found to have a
higher elastic modulus, yield strength, and ultimate
strength than unaligned specimens. This precise arrange-
ment also had a significant effect on the cellular response
to the graft, with fibroblasts attaching along the long axis
of the aligned nanofibers in contrast to the unaligned scaf-
folds where they adopted a random orientation. The pro-
cess of electrospinning has also been shown to minimize
the immune response compared with processing the same
materials into films, making it an appealing method to
produce these constructs.47
By incorporating various biological components into syn-
thetic scaffolds, their functional properties have been
enhanced. In a rabbit model of an infraspinatus tear,
Yokoya et al59 found that the addition of mesenchymal stem
cells to a PLGA sheet resulted in the formation of fibrocar-
tilage and Sharpey fibers at the insertion site. The resul-
tant enthesis also had a greater proportion of type I
collagen and a better tensile strength when compared with
controls without mesenchymal stem cells. Zhao et al61
applied basic fibroblast growth factor (bFGF)–loaded PLGA
electrospun fibrous membranes to a rat model of a chronic
rotator cuff tear and compared the results with conven-
tional repairs. Local administration of the PLGA mem-
brane was associated with improved collagen organization
and greater fibrocartilage production during the initial
phases of healing. This was accompanied by a significantly
greater ultimate load to failure, which was maintained at
progressive time points.
Few human studies examining the effect of synthetic
scaffolds on regeneration of the enthesis have been con-
ducted. In a nonrandomized retrospective 3-year follow-
up study, Ciampi et al13 compared the results of mini–open
repair of posterosuperior massive rotator cuff tears
between nonaugmented controls, augmentation with an
absorbable collagen patch, and augmentation with a syn-
thetic nonabsorbable polypropylene patch. The polypropy-
lene patch performed the best, exhibiting a significantly
lower 12-month retear rate and superior functional out-
come (using the University of California, Los Angeles
shoulder ratingscale), abduction,andelevationat36months.
No adverse reactions were related to patch application.
Proctor43 evaluated the functional results of 18 consecutive
patients with large to massive rotator cuff tears treated
with a woven mesh of absorbable poly-L-lactic acid (X-Repair;
Synthasome Inc). A combination of ultrasound and mag-
netic resonance imaging showed that 83% of patients had
intact repairs 12months after surgery. At 42months, 1 addi-
tional failure occurred, which reduced long-term survival to
78%. There was a progressive improvement in functional
outcome in the cuff repair survivor group, assessed by the
ASES scoring system, at all time points. Also investigating
this scaffold, Lenart et al33 reviewed 16 consecutivepatients
with massive or recurrent rotator cuff tears that underwent
open repair with the graft. At a mean of 1.5-year follow-up,
the ASES and the PENN Shoulder Score significantly
improved despite only 5 repairs being intact on magnetic
resonance imaging.
Although many studies investigating synthetic scaffolds
have yielded encouraging results, there are several con-
cerns over the degradation products of the polymers used
to produce them. High levels of lactic and glycolic acid have
been shown to impair osteoblast proliferation and inhibit
matrix mineralization, whereas in nontoxic concentrations,
they were found to decrease cellular proliferation and
increase differentiation of osteoblasts.38 These toxic effects
have been shown to vary between polymers, and thus fur-
ther research is required to ensure that the liberation of
these degradation products remains within safe levels for
the duration that the implant is in situ.53
DISCUSSION
Scaffolds are used to enhance healing of the rotator cuff,
but little data exist to support the hypothesis that they will
improve the biomechanical properties of the repair con-
struct. Using a validated spring network model developed
for investigating nonaugmented and augmented human
rotator cuff repairs, Aurora et al2 established that the
mechanical properties of the overall repair were primarily
influenced by the quality of tendon-bone fixation. If this is
compromised by fixation in osteopenic bone and repair of
a chronic degenerative tendon, there is a concomitant
reduction in the yield load (43%) and stiffness (62%) of the
construct. Scaffold augmentation under these circum-
stances may mitigate the reduction in mechanical proper-
ties by bearing approximately 45% of the total load.2
After implantation, scaffolds may undergo degeneration
or remodeling, but themechanism bywhich these processes
occur is still poorly understood, as are the long-term effects
of the degradation products they may release. Small intest-
inal submucosa is rendered acellular during processing and
exclusively consists of an extracellular matrix that is rap-
idly resorbed and subsequently remodeled. The resultant
structure often resembles tissue that is normally found at
the site of application; however, due to reports of immuno-
genic reactions, its use has been discouraged.37,56 To over-
come this, a number of allogenic matrices have been
manufactured from decellularized human cadaveric mate-
rial. Despite no serious complications being reported, there
have been concerns over the presence of residual DNA,
which may cause an inflammatory response and increase
tendon degeneration.22,62 Biodegradable synthetic scaffolds
have offered an alternative to more traditional biomater-
ials, but they are still in their relative infancy, with no
long-term studies available for analysis. They are created
to degrade over time into nontoxic metabolites. Scaffolds
made from nonbiodegradable polymers, although an excep-
tion, persist for the lifetime of the patient.44
Animal models provide a unique opportunity to study the
effects of scaffolds on tendon. Even so, animal models can-
not be used to accurately predict human response to bioma-
terials. The principal advantages of animal studies are that
several comparative groups may be examined simultane-
ously with robust methodology, tissues may be harvested
for analysis at several time points, and injuries can be
reproduced consistently. However, small and large animal
models do not accurately reflect the conditions within the
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human shoulder during tearing of the rotator cuff, since
many utilize quadrupeds, which subject their tendons to
different loads and entail different joint kinematics.49 The
acute tendon injuries in these models are also different
from clinical scenarios, which often entail degeneration of
the rotator cuff prior to the tear.26
Scaffolds have received considerable attention in the lit-
erature and formulate an important part of the shoulder
surgeon’s armamentarium for the treatment of complex
tears of the rotator cuff. Despite a number of novel bioma-
terials being developed into biologically and mechanically
favorable constructs, there is a paucity of clinical trials
examining their effects on tendon-bone healing in well-
designed, long-term follow-up studies with appropriate con-
trol groups.5,27 Indications for the use of scaffolds are also
inconsistent between studies, and therefore, current evi-
dence cannot be used to inform management of specific
patient groups such as older individuals who are prone to
poorer outcomes and tears with fatty infiltration.52
CONCLUSION
Over the past decade, there has been an increasing trend
toward operative intervention for the treatment of rotator
cuff tears. With an aging population, it is likely to represent
one of themost common soft tissue procedures performed in
the future. To improve current surgical outcomes, it is
imperative that new augmentation techniques are evalu-
ated with long-term follow-up studies so that the precise
effect of the scaffold and its degradation products can be
determined. Evaluation should assess patient-reported out-
comes, function, and imaging of the repair. Animal studies
also have an important role in the examination of the
tendon-bone interface, but models should attempt to repro-
duce the degree of chronicity often present in the torn rota-
tor cuff. The literature thus far has evaluated scaffolds,
growth factors, and some biologically enhanced materials,
although none have been able to regenerate the mechanical
properties of a normal, graded enthesis. While there is still
considerable work to be done before scaffolds are intro-
duced into routine clinical practice, there does appear to
be a clear indication for their use as an interpositional graft
for large and massive retracted rotator cuff tears and when
repairing a poor-quality degenerative tendon.
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